Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.
Korean J Intern Med. 2013 Jul;28(4):428-38. doi: 10.3904/kjim.2013.28.4.428. Epub 2013 Jul 1.
BACKGROUND/AIMS: Recurrence after hepatic resection is one of the most important factors impacting the prognosis and survival of patients with hepatocellular carcinoma (HCC). We identified prognostic factors affecting overall survival (OS) and disease-free survival (DFS) in patients with HCC after hepatic resection.
This study was of a retrospective cohort design, and 126 patients who underwent hepatic resection for HCC at Gachon University Gil Medical Center between January 2005 and December 2010 were enrolled. Various clinical, laboratory, and pathological data were evaluated to determine the prognostic factors affecting OS and DFS.
Two- and 4-year OS and 2- and 4-year DFS were 78.1% and 65% and 51.1% and 26.6%, respectively. In a multivariate analysis, preoperative α-fetoprotein (> 400 ng/mL), tumor size (≥ 5 cm), multiple tumors (two or more nodules), presence of portal vein invasion, modified Union for International Cancer Control (UICC) stage III/IV, and Barcelona Clinic Liver Cancer (BCLC) stage B/C were independent prognostic factors affecting a shorter OS. In the multivariate analysis, presence of microvascular invasion, modified UICC stage III/IV, and BCLC stage B/C were independent prognostic factors for a shorter DFS.
The presence of vascular invasion was an independent poor prognostic factor for OS and DFS in patients with HCC after hepatic resection. Thus, close postoperative surveillance for early detection of recurrence and additional treatments are urgently needed in patients with vascular invasion after hepatic resection.
背景/目的:肝切除术后复发是影响肝细胞癌(HCC)患者预后和生存的最重要因素之一。我们确定了影响 HCC 患者肝切除术后总生存(OS)和无病生存(DFS)的预后因素。
本研究为回顾性队列设计,纳入 2005 年 1 月至 2010 年 12 月期间在加图大学吉尔医疗中心接受 HCC 肝切除术的 126 例患者。评估了各种临床、实验室和病理数据,以确定影响 OS 和 DFS 的预后因素。
2 年和 4 年 OS 率和 2 年和 4 年 DFS 率分别为 78.1%和 65%以及 51.1%和 26.6%。多因素分析显示,术前甲胎蛋白(>400ng/mL)、肿瘤大小(≥5cm)、多发病灶(两个或更多结节)、门静脉侵犯、改良国际抗癌联盟(UICC)分期 III/IV 期和巴塞罗那临床肝癌(BCLC)分期 B/C 是影响 OS 较短的独立预后因素。在多因素分析中,微血管侵犯的存在、改良 UICC 分期 III/IV 期和 BCLC 分期 B/C 是影响 DFS 较短的独立预后因素。
血管侵犯的存在是 HCC 患者肝切除术后 OS 和 DFS 的独立不良预后因素。因此,在肝切除术后有血管侵犯的患者中,迫切需要密切的术后监测以早期发现复发并进行额外的治疗。